跳至主要内容
临床试验/CTIS2023-504230-21-00
CTIS2023-504230-21-00进行中(未招募)1 期

A blinded randomized study of neostigmine/glycopyrrolate 50 mikrogram/kg or sugammadex 2 mg/kg for reversal of neuromuscular blockade in elderly patients (= 75 years)

Rigshospitalet0 个研究点目标入组 1 人开始时间: 2023年3月10日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65 至 65+(—)
性别
All

入选标准

  • 1)Patients = 75 years old, 2)Informed consent, 3)Scheduled for robotic assisted laparoscopic surgery under general anesthesia with intubation and use of rocuronium during the entire operation, 4)American Society of Anesthesiologists (ASA) physical status classification I to IV, 5)Can read and understand Danish

排除标准

  • 1)Known allergy to rocuronium, sugammadex or neostigmine/glycopyrrolate, 2)Neuromuscular disease that may interfere with neuromuscular data, 3)Severe renal impairment defined as eGFR < 30 ml/min, 4)Indication for rapid sequence induction

研究者

相似试验